Deflazacort - Generic Drug Details

What are the generic sources for deflazacort and what is the scope of patent protection?

Deflazacort is the generic ingredient in one branded drug marketed by Ptc Therap and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for deflazacort.

Summary for deflazacort

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	2
Drug Master File Entries:	3
Raw Ingredient (Bulk) Api Vendors:	71
Clinical Trials:	23
Patent Applications:	7,529
What excipients (inactive ingredients) are in deflazacort?	deflazacort excipients list
DailyMed Link:	deflazacort at DailyMed

Recent Clinical Trials for deflazacort

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Parc de Salut Mar	Phase 1
FibroGen	Phase 3
Catabasis Pharmaceuticals	Phase 1

See all deflazacort clinical trials

US Patents and Regulatory Information for deflazacort

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-004	Feb 9, 2017		RX	Yes	Yes
Ptc Therap	EMFLAZA	deflazacort	SUSPENSION;ORAL	208685-001	Feb 9, 2017		RX	Yes	Yes
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-004	Feb 9, 2017		RX	Yes	Yes
Ptc Therap	EMFLAZA	deflazacort	SUSPENSION;ORAL	208685-001	Feb 9, 2017		RX	Yes	Yes
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-002	Feb 9, 2017		RX	Yes	No
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-002	Feb 9, 2017		RX	Yes	No
Ptc Therap	EMFLAZA	deflazacort	TABLET;ORAL	208684-001	Feb 9, 2017		RX	Yes	No